Hexagons on blue gradient background

PODD Conference 2024: Oral peptide panel presentation

Boston, MA, United States | 28 October 2024 - 29 October 2024
Overview

Join us at the PODD Conference this October

Quotient Sciences is pleased to be sponsoring and participating in this program. The 14th Annual event will present the latest trends in innovative drug delivery technologies.   

Dr. Andrew Lewis, Chief Scientific Officer, will be speaking this panel discussion:  

Achieving Oral Delivery of Peptides Through Formulation and Molecular Design Approaches. 

DateLocationTime
October 29thTrack 13:35 PM

To learn more about advances in oral peptides and Quotient Sciences' CDMO/CRO capabilities, schedule a meeting to speak with Andy at the event.

Request a Meeting
Location
Westin Boston Seaport
425 Summer St. , MA 02210
Boston, MA, United States

Meet our expert:

We look forward to meeting with you at PODD this October.

Dr. Andrew Lewis

Chief Scientific Officer

Dr. Andrew (Andy) Lewis is the Chief Scientific Officer at Quotient Sciences. As the leader of Quotient Sciences' scientific teams...

About Andrew
Daniel Dennehy

Director, Business Development

I am an accomplished Business Development Director with over 10 years’ experience in sales to healthcare, pharmaceutical, and acad...

About Daniel
Nabil Lally

Senior Director, Business Development

My tenure at Quotient Sciences is marked by pioneering the Translational Pharmaceutics platform, delivering an average of 12 month...

About Nabil

More insight from our experts:

Read More
Peptides, Dr. Andrew Lewis, Dr. Stuart Mair Unlocking the Potential of GLP-1 Agonists: Q&A with Dr. Andrew Lewis and Dr. Stuart Mair By: Dr. Andrew Lewis and Dr. Stuart Mair
Learn more
Translational Pharmaceutics, Clinical Pharmacology, Peptides, Modified Release, Formulation Development, Dr. Andrew Lewis, Dr. Stuart Mair Exploring GLP-1 Agonists: How they work and what the future holds for this promising treatment By: Dr. Andrew Lewis
Learn more